Glaukos Receives Permanent J-code for iDose® TR (travoprost intracameral implant)
New J-code for iDose TR®, J7355, set to become effective July 1, 2024ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an...
Year: 2024
HSG Advisors Releases Healthcare Dashboard Leveraging Proprietary Data to Drive Strategic Growth for Clients
Dashboard Gives Clients a Way to Access, Visualize, and Analyze Complex Internal and External Data SetsLOUISVILLE, KY / ACCESSWIRE /...
Aytu BioPharma to Present at the Emerging Growth Conference on April 4, 2024
Webcasted presentation to take place at 4:40 p.m. Eastern timeDENVER, CO / ACCESSWIRE / April 3, 2024 / Aytu BioPharma,...
Allara Health Announces New Study That Reveals Significant Productivity Loss Due to Polycystic Ovary Syndrome (PCOS), Highlights Racial and Mental Health Factors
SAN FRANCISCO, CA / ACCESSWIRE / April 3, 2024 / Allara Health released the first study to investigate the impact...
Bausch Health, Canada Inc. Announces First Public Drug Plan Listings for (Pr)UCERIS(R) (budesonide) Aerosol Foam to Help Address the Unmet Need for the Treatment of Mild to Moderate Distal Ulcerative Colitis in Adults
LAVAL, QC / ACCESSWIRE / April 3, 2024 / Bausch Health, Canada Inc., part of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC),...
InspireMD to Present at the 23rd Annual Needham Virtual Healthcare Conference
TEL AVIV, Israel and MIAMI, April 03, 2024 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic...
Imidex Hires Wes Bolsen as CEO to Commercialize FDA-Cleared Artificial Intelligence Device for Lung Nodule and Mass Detection, Indicative of Potential Early-Stage Lung Cancer
Company is evaluating strategic partners and potential acquirers who could potentially treat 50% more lung nodule patients in the U.S....
Asensus Surgical, Inc. Announces Non-Binding Acquisition Proposal and Exclusivity Arrangement with KARL STORZ SE & Co. KG
KARL STORZ to provide up to $20 million in bridge financingRESEARCH TRIANGLE PARK, N.C., April 03, 2024 (GLOBE NEWSWIRE) --...
Surrozen Publishes Study in ‘Respiratory Research’ Demonstrating the Promise of a Wnt Mimetic Antibody in Treating Pulmonary Fibrosis
In a preclinical model of pulmonary fibrosis, a Surrozen antibody-based SWAP platform molecule decreased pulmonary inflammation and fibrosis and improved...
Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within PRC Alliance Pain Relief Center in Ormond Beach, Florida
PRC Alliance Pain Relief Center operates 8 locations across central Florida Dr. Bakshi reports 100% success performing Epidural Steroid Injection...
Lisata Therapeutics to Participate in Upcoming April 2024 Industry and Investor Events
BASKING RIDGE, N.J., April 03, 2024 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage...
TOMI Environmental Solutions Receives Gold Safety Award from Highwire
FREDERICK, Md., April 03, 2024 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in...
For World Mental Health Day, Jack.org Calls on Communities Across the Country to Come Together to End the Youth Mental Health Emergency
Jack.org invites you to Canada’s Ride for Youth Mental Health to support life-changing mental health programs for young people CAPTION:...
Matinas BioPharma Prices $10 Million Registered Direct Offering
BEDMINSTER, N.J., April 03, 2024 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB) (“Matinas BioPharma” or the “Company”), a...
BioCorRx Pharmaceuticals Inc. Awarded New Patent for Novel Compound to Treat Pain, Depression, and Schizophrenia
ANAHEIM, CA, April 03, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer of...
Inhibikase Therapeutics Announces Pre-IND Meeting with the FDA for IkT-001Pro in Pulmonary Arterial Hypertension
Meeting to discuss potential of IkT-001Pro as a disease modifying treatment for Pulmonary Arterial HypertensionBOSTON and ATLANTA, April 03, 2024...
Tevogen Bio Appoints Tapan V Shah as Head of Investor Relations and Corporate Development
WARREN, N.J., April 03, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc (‘Tevogen Bio’) (Nasdaq: TVGN), a clinical-stage biotech company,...
“Cutest Pets on Parliament Hill” Photo Contest: Politics and Pets Collide
TORONTO, April 03, 2024 (GLOBE NEWSWIRE) -- In a celebration of the importance of furry companionship amidst the hustle and...
CytomX Therapeutics Announces Nomination of Second Clinical Candidate in Broad PROBODY® T-Cell Engaging Bispecific (TCB) Collaboration with Astellas
- Achievement of latest clinical candidate triggers additional $5 million milestone payment to CytomX and is the third milestone achieved...
Lipella Pharmaceuticals Announces FDA Type C Meeting for LP-10 for Hemorrhagic Cystitis
PITTSBURGH, April 03, 2024 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (Nasdaq: “LIPO”) (“Lipella,” “our,” “us” or the “Company”), a clinical-stage...